Discovery of dual-degrading compound could pave way for more effective cancer drugs
UF College of Pharmacy researchers Daohong Zhou, Guangrong Zheng and Yaxia Yuan developed a new compound that simultaneously attacks two key proteins critical for a cancer cell’s survival.